HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 22.20% | 9.61% | -0.57% | -125.17% | -34.02% |
| Total Depreciation and Amortization | -53.58% | -34.60% | -30.67% | -5.41% | -6.31% |
| Total Amortization of Deferred Charges | -39.00% | -29.53% | -12.58% | -2.06% | -4.31% |
| Total Other Non-Cash Items | 69.79% | 132.36% | -61.97% | 133.27% | -38.31% |
| Change in Net Operating Assets | -8.63% | 22.43% | 4.23% | 28.44% | 67.45% |
| Cash from Operations | 26.53% | 40.32% | -8.99% | -28.59% | -36.44% |
| Capital Expenditure | 26.19% | 100.00% | 96.56% | 98.11% | 91.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -165.53% | 15.76% | 403.99% | 80.37% | 301.03% |
| Cash from Investing | -165.74% | 17.98% | 687.68% | 80.72% | 293.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 42.86% | -400.91% | -1,382.75% | -1,433.52% | -726.86% |
| Issuance of Common Stock | -- | 2,336.44% | -- | -- | 7.82% |
| Repurchase of Common Stock | 97.53% | 42.86% | -5,714.29% | -72,714.29% | -575.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.64% | 33.60% | 9.40% | 171.24% | -72.24% |
| Cash from Financing | -123.54% | 23,085.67% | -1,485.01% | -143.09% | -14.73% |
| Foreign Exchange rate Adjustments | 208.33% | 748.48% | -142.59% | -578.26% | 62.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -283.76% | 1,529.00% | 23.98% | -8.01% | 908.66% |
